Note we may have some server downtime today and this weekend as we perform some upgrades. Please save a copy of any posts you make during this time in case we have any server trouble. Thank you!

US FDA accepts MS drug Lemtrada resubmission for review

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

US FDA accepts MS drug Lemtrada resubmission for review

Postby MSUK » Tue Jun 03, 2014 8:29 am

The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2109
Joined: Wed Oct 14, 2009 3:00 pm

Return to Campath (Lemtrada, Alemtuzumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service